By: Elizabeth Cairns
A million patients with obesity are already taking Novo Nordisk's Wegovy pill, CEO Mike Doustdar said Wednesday, despite the market entry of …
Elizabeth Cairns is a Senior Biopharma Journalist at Informa. She specializes in covering themes related to medicine and healthcare, pharmaceuticals, and public health, with a focus on topics such as drugs and medication, pharmaceutical regulation, and patient care. Elizabeth's work has been featured in notable publications including Citeline and Endpoints News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston


Not enough data
Elizabeth Cairns' coverage primarily focuses on the healthcare and pharmaceutical industry, with a strong emphasis on biopharmaceuticals, clinical trials, drug development, and medical research. She frequently cites data and press releases in her articles.
If you are looking to reach out to Elizabeth Cairns for potential coverage or collaboration opportunities, consider offering access to exclusive data or insights related to breakthroughs in drug development or clinical trial results. Given her focus on scientific themes as well as private sector announcements, she might be interested in pitches that provide unique perspectives from key figures within pharmaceutical companies regarding new developments and trends shaping the industry.
This information evolves through artificial intelligence and human feedback. Improve this profile .